You searched for Antibody candidate - Page 62 of 69

News and Trends 8 Jan 2018

Bang and the Wart is Gone! Norwegian Peptide Destroys HPV-Infected Cells

…treatment of dermatological problems, including cutaneous warts caused by human papillomavirus. It lead candidate, CyPep-H1, uses a new mechanism of action to specifically target and destroy cells infected by the…

January 8, 2018 - 3 minutesmins - By Alex Dale

News and Trends 1 Feb 2017

Stem Cell Therapy for Sepsis in Pneumonia advances to Phase II

TiGenix has treated the first patient in a new early-stage clinical trial to test its candidate Cx611 as a treatment for sepsis in patients with pneumonia. TiGenix, based in Belgium,…

February 1, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

tumor cancer immunotherapy alderaan biotech

News and Trends 17 Jun 2020

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

…candidate is already in phase II clinical trials for the treatment of solid tumors. In contrast to Ona’s project, which focuses on fat metabolism, Vigeo’s candidate causes cells to produce…

June 17, 2020 - 2 minutesmins - By Victor Kotsev

News and Trends 29 Jun 2017

New Drug for Neuropathic Pain Is Forging its Way through the Clinic

…to move its compound towards the next stage of clinical development. The peptide candidate was shown to be safe and well-tolerated and inhibited both of its target enzymes, aminopeptidase N…

June 29, 2017 - 3 minutesmins - By Melanie De Almeida

In Depth 4 Jan 2021

What Does the Next Decade Have in Store for European Biotech?

…identify drug candidates against a specific target. This can significantly reduce the time it takes to select a drug candidate to start clinical testing. A recent example is that of…

January 4, 2021 - 9 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 28 Mar 2018

AI Is Being Put to Work to Treat Parkinson’s Disease in the UK

The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to identify ideal drug candidates for treating Parkinson’s disease. BenevolentAI, Europe’s largest private AI company, is…

March 28, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 19 Dec 2022

Nykode Therapeutics and Richter-Helm BioLogics announce partnership

…compliance for clinical trials and late-stage product candidates,” said Kai Pohlmeyer, managing director of Richter-Helm BioLogics. Manufacturing is a strategic focus area for Nykode and its license partners. Under the…

December 19, 2022 - 3 minutesmins - By Jim Cornall

galapags ulcerative colitis gilead trials

News and Trends 26 Jan 2016

Gilead On Board, But Still No Easy Sailing for Galapagos with Phase IIa Failure

…We speculate. However, Galapagos have also just released phase IIa trials for another candidate (GLPG1205) in Ulcerative Colitis. Whilst good safety and tolerability profiles for this small-molecule candidate were found,…

January 26, 2016 - 2 minutesmins - By Dani Bancroft

car t cd19 fda juno therapeutics cerebral edema

News and Trends 18 Jul 2016

UPDATED: Storm on the CAR-T field – 3 patients die in Phase II Study

…most CAR-T Biotechs share the same target? UPDATE (article originally published on 8/7/2016): the FDA has allowed Juno Therapeutics to resume its CAR-T trial with JCAR015, the Biotech’s leading candidate….

July 18, 2016 - 5 minutesmins - By Denise Neves Gameiro

Best in Biotech 22 May 2023

Five recent advancements in arthritis research over the past year

…Month in May, here are five recent advancements in arthritis research over the past year. Acelyrin’s drug candidate advances in phase 2 clinical trials for psoriatic arthritis treatment For the…

May 22, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 15 Oct 2019

German Cancer Virotherapy Biotech Launches with €12M Series A

…the arenavirus candidates that Abalos is developing will rely on the patient’s immune system to target cancer cells. According to the company, replication of its arenavirus candidates in the targeted…

October 15, 2019 - 2 minutesmins - By Helen Albert

News and Trends 19 Oct 2022

Aqemia raises €30M for AI-enabled drug discovery pipeline

…said its ambition is to optimize and accelerate early drug discovery projects on a massive scale in order to uncover dozens of proprietary new drug candidates. Those candidates will fuel…

October 19, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Bang and the Wart is Gone! Norwegian Peptide Destroys HPV-Infected Cells

Stem Cell Therapy for Sepsis in Pneumonia advances to Phase II

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

New Drug for Neuropathic Pain Is Forging its Way through the Clinic

What Does the Next Decade Have in Store for European Biotech?

AI Is Being Put to Work to Treat Parkinson’s Disease in the UK

Nykode Therapeutics and Richter-Helm BioLogics announce partnership

Gilead On Board, But Still No Easy Sailing for Galapagos with Phase IIa Failure

UPDATED: Storm on the CAR-T field – 3 patients die in Phase II Study

Five recent advancements in arthritis research over the past year

German Cancer Virotherapy Biotech Launches with €12M Series A

Aqemia raises €30M for AI-enabled drug discovery pipeline

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!